A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours.

This is an open-label, single-arm, dose escalation clinical study to evaluate the safety and preliminary efficacy of OVV-01 Injection in patients with advanced solid tumors, following both intravenous (iv.) and intratumoral (it.) injections. This study consists of two parts: Part 1 is a dose escalation study of iv. administration; Part 2 is a dose escalation study of iv. and it. administration.

NCT Number	NCT07648472
Lead Sponsor	Joint Biosciences Ltd. Collaborators: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions	Advanced Solid Tumors
Enrollment	18 participants
Start Date	2026-04-21
Primary Completion	2027-04-20 (estimated)
Study Completion	2027-04-20 (estimated)
Updated on ClinicalTrials.gov	2026-06-15